# Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty

> **NCT02701296** · NA · COMPLETED · sponsor: **Trinity Health Of New England** · enrollment: 80 (actual)

## Conditions studied

- Posterior Knee Infiltration

## Interventions

- **DRUG:** Ropivacaine with Epinephrine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT02701296
- **Lead sponsor:** Trinity Health Of New England
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-07
- **Primary completion:** 2014-08-31
- **Final completion:** 2014-08-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701296, "Posterior Capsular Injection With Femoral Nerve Block for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02701296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*